Attached files

file filename
EX-99 - EXHIBIT 99.1 - CASSAVA SCIENCES INCexh_991.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K/A
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 4, 2011
 
Pain Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
 
DELAWARE
 
000-29959
 
91-1911336
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
7801 N Capital of Texas Highway, Suite 260, Austin, Texas 78731
(Address of principal executive offices, including zip code)
 
512-501-2444
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
*EXPLANATORY NOTE – Following the initial filing of this Form 8-K, the Registrant discovered that the EDGAR filer inadvertently checked the wrong item tag in the submission (item 1.01, rather than 2.02). The Registrant is amending this Form 8-K to include the correct item tag. No disclosure was changed as a result of this error.
 
Results of Operations and Financial Condition.
 
On August 4, 2011 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
Financial Statements and Exhibits.

  Exhibit 99.1. Press release dated August 4, 2011 
 

 
SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
PAIN THERAPEUTICS, INC.
 
Dated: August 4, 2011
By:  
/s/ Peter S. Roddy  
 
 
 
Peter S. Roddy
 
 
 
Vice President and Chief Financial Officer